Literature DB >> 18931647

Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression.

Kandelaria M Rumilla1, Lori A Erickson, F John Service, Adrian Vella, Geoffrey B Thompson, Clive S Grant, Ricardo V Lloyd.   

Abstract

Hypoglycemia secondary to nesidioblastosis is rare in adults, and the pathogenesis of this condition is unknown. To determine factors leading to nesidioblastosis in adults, we analyzed 36 cases of nesidioblastosis including 27 cases of postgastric bypass nesidioblastosis and 9 cases of idiopathic nesidioblastosis in adults by immunohistochemistry using antibodies to insulin-like growth factor 1, insulin-like growth factor 2 (IGF2), insulin-like growth factor one receptor-alpha epidermal growth factor receptor, transforming growth factor-beta1 and 2, and transforming growth factor-beta receptor type 3. Fifty-two surgically excised pancreatic specimens from patients with benign exocrine tumors and no evidence of hypoglycemia were used as controls. There was increased IGF2, insulin-like growth factor receptor 1 receptor-alpha and transforming growth factor-beta receptor 3 expression in islets from nesidioblastosis patients compared to controls. Peliosis-type vascular ectasia was more common in nesidioblastosis patients compared to controls. These findings suggest that increased production of growth factors and growth factor receptors may contribute to the development of nesidioblastosis in adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931647     DOI: 10.1038/modpathol.2008.169

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.

Authors:  Zhen Li; Hong-Ya Zhang; Lu-Xian Lv; Dong-Fei Li; Jing-Xing Dai; Ou Sha; Wen-Qiang Li; Yu Bai; Lin Yuan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.

Authors:  Juan Patricio Valderas; Jessica Ahuad; Lorena Rubio; Manuel Escalona; Felipe Pollak; Alberto Maiz
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

3.  Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.

Authors:  Scott M Thompson; Adrian Vella; Geoffrey B Thompson; Kandelaria M Rumilla; F John Service; Clive S Grant; James C Andrews
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

4.  Back to Sleeve: an Extreme Solution for Specific Complications of the Roux-en-Y Gastric Bypass.

Authors:  Anne-Sophie Schneck; Fabien Stenard; Antonio Iannelli
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

Review 5.  Benign Tumors and Tumorlike Lesions of the Pancreas.

Authors:  Olca Basturk; Gokce Askan
Journal:  Surg Pathol Clin       Date:  2016-12

Review 6.  Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass.

Authors:  Yunfeng Cui; Dariush Elahi; Dana K Andersen
Journal:  J Gastrointest Surg       Date:  2011-06-14       Impact factor: 3.452

Review 7.  Surgical Treatment for Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass: a Literature Review.

Authors:  Qiang Xu; Xi Zou; Lei You; Wenming Wu; Huijuan Zhu; Linjie Wang; Tao Yuan; Yupei Zhao
Journal:  Obes Surg       Date:  2021-02-01       Impact factor: 4.129

8.  Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass.

Authors:  Mary-Elizabeth Patti; Allison B Goldfine; Jiang Hu; Dag Hoem; Anders Molven; Jeffrey Goldsmith; Wayne H Schwesinger; Stefano La Rosa; Franco Folli; Rohit N Kulkarni
Journal:  Acta Diabetol       Date:  2017-05-17       Impact factor: 4.280

9.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

Review 10.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.